Developer docs
API playgroundTry for free, no card

Search company profiles

Molecular Diagnostic Services

Full company profile

uuid002nfw9

Namestring
Molecular Diagnostic Services
Legal namestring
Molecular Diagnostic Services, Inc.
Websiteurl
mds-usa.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Molecular Diagnostic Services, Inc. (MDS) is a privately held U.S. Contract Research Organization (CRO) founded in 1992 and headquartered in San Diego, California. The company provides a broad portfolio of molecular diagnostics, cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility testing services to pharmaceutical, biotechnology, medical device companies, and research institutions. Services are delivered under both GLP-compliant protocols for regulatory submissions (recognized by FDA, EPA, OECD, EEC, JMHW, and JMAFF) and non-GLP study formats for discovery-stage research, with confidentiality and direct technical-staff access positioned as core client-facing principles.

The underlying technology platform is a conventional wet-lab stack spanning PCR (endpoint and TaqMan quantitative real-time), flow cytometry and cell sorting, FISH, G-band karyotyping across multiple mammalian species, STR and SNP genotyping, DNA fingerprinting, Ames and mammalian gene mutation assays, chromosome aberration and micronucleus tests, GLP/GMP-grade plasmid DNA production, and GLP-compliant in vivo animal studies. The wholly-owned RRDA division maintains an AAALAC-, USDA-, and NIH-accredited vivarium that supplies toxicology, PK/ADME, vaccine efficacy, immunogenicity, and medical device testing in rabbits and rodents, plus short- and long-term vivarium leasing.

MDS operates as a project-based, quote-priced CRO with no publicly disclosed fee schedules. Go-to-market is direct enterprise engagement — primarily field sales and relationship-driven — supported by a company website (mds-usa.com), downloadable submission forms, a newsletter channel, and facility audit invitations. Revenue is generated through fee-for-service contracts, with the firm employing between 11 and 50 staff and reporting no parent company, venture capital, or private equity affiliations.

Short descriptiontext

Molecular Diagnostic Services is a privately held San Diego-based Contract Research Organization, founded in 1992, providing GLP-compliant molecular diagnostics, toxicology, microbiology, sterility assurance, and biocompatibility testing to pharmaceutical, biotechnology, medical device, and research clients, including in vivo animal studies via its RRDA vivarium division.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
contract research services, GLP-compliant testing, molecular diagnostics, preclinical toxicology, biocompatibility testing
Industry3 codes
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Testing Laboratories and Services541380
  • Medical Laboratories621511
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (CRO) Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

MDS operates as a Contract Research Organization providing comprehensive testing services to pharmaceutical, biotechnology, medical device, and research institutions. Revenue is generated through project-based testing contracts for GLP-compliant and non-GLP studies covering molecular diagnostics, toxicology, microbiology, sterility assurance, and biocompatibility services.

mds-usa.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Molecular Diagnostic Services, Inc. is an independent Contract Research Organization (CRO) operating since 1992, providing comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility testing services to pharmaceutical, biotechnology, medical device, and research institutions. Services are offered both as GLP-compliant studies for regulatory submission (FDA, EPA, OECD, EEC, JMHW, JMAFF) and non-GLP screening for product research and development. The RRDA division adds an AAALAC/USDA/NIH-accredited vivarium for in vivo toxicology, PK/ADME, vaccine efficacy, and surgical procedures.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Molecular Diagnostic Services is an independent Contract Research Organization (CRO) operating since 1992, providing comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility services to pharmaceutical, biotechnology, medical device, and research institutions. The company offers a broad portfolio of testing services designed for both GLP-compliant regulatory submission and non-GLP screening for product research and development. Key service areas include Molecular Diagnostics, Clinical Trial Services, Animal Testing Services (through the RRDA division), Antibody Services, Blood Chemistry, Endocrinology, EPA Services, Genotyping, Hematology, Histology, Cell Bank Qualification, In Vivo and In Vitro Toxicity Studies, Immunogenicity, Immunotoxicology, Microbiology, Mutagenesis, Stem Cell Services, Sterility Testing, Vaccine Testing, and Biostatistical Analysis. The company also provides specialized services such as Flow Cytometry, PCR Services (Endpoint, Q-PCR, Species-Specific), DNA Sequencing, FISH Services, Plasmid DNA Production, Custom Cloning, Transgenic Testing, and Expert Witness Services. Services are available for various species including human, murine, bovine, porcine, equine, avian, and others.

Product and service22 records
1Molecular Diagnostics
CategoryMolecular Diagnostics
Description

Core molecular biology testing services including cellular and molecular biology analysis for pharmaceutical, biotechnology, medical device, and research institutions.

2Clinical Trial Services
CategoryClinical Trial Services
Description

Clinical trial support services for regulatory-compliant product testing and evaluation.

3Rabbit and Rodent Diagnostic Associates (RRDA) Animal Testing Services
CategoryAnimal Testing Services
Description

Animal testing services offering an AAALAC, USDA, and NIH accredited vivarium with GLP or non-GLP toxicology, PK, ADME, drug efficacy, vaccine efficacy, immunogenicity studies, medical device testing, and surgical procedures for laboratory animals. Also offers vivarium space on short or long-term leases.

4Antibody Services
CategoryAntibody Services
Description

Antibody production and characterization services for research and development applications.

5Blood Chemistry R&D and CLIA-certified Blood Chemistry
CategoryClinical Chemistry
Description

Blood chemistry testing services for research and development and CLIA-certified clinical diagnostic applications.

6Endocrinology Services
CategoryEndocrinology
Description

Endocrine testing and analysis services.

7EPA Services
CategoryRegulatory Testing
Description

Environmental Protection Agency-compliant testing services for pesticides and other regulated products.

8Genotyping Services
CategoryGenotyping
Description

DNA genotyping services including SNP analysis, STR profiling, DNA fingerprinting, and species identification.

9Hematology R&D and CLIA-certified Hematology
CategoryHematology
Description

Hematology testing services for research and CLIA-certified clinical diagnostics.

10Histology R&D and CAP-certified Histology
CategoryHistology
Description

Histological analysis and pathology services including H&E slide preparation and interpretation.

11Cell Bank Qualification
CategoryCell Banking
Description

Characterization and qualification of cell banks including Master Cell Banks (MCB) and Working Cell Banks (WCB), covering genetic stability, adventitious agent testing, and cell aging characterization.

12In Vivo Toxicity Studies
CategoryToxicology
Description

GLP-compliant in vivo toxicity testing for pharmaceuticals, biopharmaceuticals, medical devices, and pesticides.

13In Vitro Toxicity Studies
CategoryToxicology
Description

In vitro toxicology testing including genetic toxicity, compound evaluation, and ADME studies.

14Immunogenicity and Immunotoxicology Services
CategoryImmunology
Description

Immunogenicity testing to evaluate immune responses to pharmaceutical and biological products, and immunotoxicity assessment for evaluating adverse immune effects of test articles.

15Microbiology Services
CategoryMicrobiology
Description

Microbiological testing including bacterial, fungal, mycoplasma detection and identification, microbial identification via 16S rRNA sequencing, environmental monitoring under 21 CFR 58, endotoxin (LAL) testing, and bioburden determination per USP <61>.

16Mutagenesis Services
CategoryGenetic Toxicology
Description

In vitro and in vivo mutagenesis testing including Ames assay, mammalian gene mutation tests, and chromosomal aberration assays.

17Stem Cell Services
CategoryStem Cell Services
Description

Stem cell culture, characterization, differentiation monitoring, and pluripotency evaluation for therapy development, including pluripotency PCR signature, signaling pathway analysis, and phenotypic characterization.

18Sterility Testing
CategorySterility Testing
Description

Biosafety and pharmacopeial sterility testing of biologics and biopharmaceuticals following USP, JP, EP, ICH, 21 CFR, and FDA Points to Consider guidance, including direct inoculation, membrane filtration, preservative efficacy, and bioburden determination.

19Vaccine Testing Services
CategoryVaccine Testing
Description

Characterization and qualification of viral, bacterial, and plasmid DNA vaccines including MCB/WCB characterization, bulk plasmid product release assays, final product release testing, potency, safety, sterility, purity, quantity, identity, endotoxin, DNA sequence analysis, and DNA vaccine modification testing.

20Biostatistical Analysis
CategoryBiostatistics
Description

Statistical analysis services for research and clinical trial data.

21Plasmid DNA Production (R&D and GLP/GMP grade)
CategoryPlasmid Production
Description

Production of reagent (R&D) grade and GLP/GMP-grade plasmid DNA from microgram to multi-gram amounts, including cell banking, cloning, transfection, and full QC release testing with stringent purity requirements for low endotoxin, host cell chromosomal DNA, and RNA contamination.

22Expert Witness Services
CategoryExpert Witness Services
Description

Expert witness testimony services for patent infringement litigation using GLP- and GMP-compliant testing.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Integrated CRO with preclinical toxicology, genetic toxicology, molecular biology, and bioanalytical services supporting pharma and biotech drug development. Comparable GLP-compliant service portfolio and similar mid-sized CRO positioning to MDS.

TypeBroad incumbent
Description

Global CRO/CDMO with preclinical toxicology, molecular biology, and biologics testing capabilities that overlap MDS's service portfolio. Its scale, integrated discovery-to-manufacturing model, and aggressive pricing pressure small specialized CROs like MDS in pharma outsourcing decisions.

TypeDirect peer
Description

California-based preclinical CRO offering GLP-compliant toxicology, biocompatibility, microbiology, and analytical chemistry testing — a close geographic and capability peer to MDS serving the same San Francisco Bay Area and broader US biotech client base.

TypeBroad incumbent
Description

Global preclinical CRO offering toxicology, genetic toxicology, molecular biology, and vivarium services that directly overlap MDS's core offerings. A dominant incumbent with vastly greater scale, multi-site capacity, and bundling power that competes for the same pharma/biotech preclinical study budgets.

TypeBroad incumbent
Description

Global clinical and preclinical CRO offering toxicology, genetic toxicology, and molecular biology testing at very large scale. Competes with MDS for both large pharma preclinical packages and provides centralized lab alternatives for biotech sponsors.

TypeDirect peer
Description

Preclinical CRO and contract research organization providing toxicology, pathology, and animal model services with GLP compliance. Competes with MDS's RRDA vivarium capabilities and in vivo toxicology services for the same pharma/biotech study budgets.

TypeDirect peer
Description

Mid-sized analytical and microbiology testing CRO with GLP-compliant services for pharma, biopharma, and medical device companies. Offers overlapping microbiology, sterility, and analytical testing capabilities that compete with MDS's biosafety service line.

8NorthEast BioLab
TypeRegional player
Description

US-based molecular biology and GLP-compliant testing CRO serving pharma and biotech with PCR, sequencing, and cell line characterization services — a regional player offering similar molecular specialty capabilities to MDS but with a different US geography focus.

TypeDirect peer
Description

Specialized biosafety testing and characterization services for biologics, vaccines, and cell therapy products — including sterility, mycoplasma, adventitious agent testing, and cell line authentication — directly mirroring MDS's biosafety/molecular diagnostic service lines.

TypeBroad incumbent
Description

International testing services group with significant molecular biology, microbiology, sterility, and GLP-compliant testing operations. Competes with MDS for biotech testing contracts and offers similar genetic toxicology, vaccine testing, and cell bank characterization services at much larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molecular Diagnostic Services

Contract Research Organization (CRO) Servicesmds-usa.com

Molecular Diagnostic Services is a privately held San Diego-based Contract Research Organization, founded in 1992, providing GLP-compliant molecular diagnostics, toxicology, microbiology, sterility assurance, and biocompatibility testing to pharmaceutical, biotechnology, medical device, and research clients, including in vivo animal studies via its RRDA vivarium division.

What Molecular Diagnostic Services does

Molecular Diagnostic Services, Inc. (MDS) is a privately held U.S. Contract Research Organization (CRO) founded in 1992 and headquartered in San Diego, California. The company provides a broad portfolio of molecular diagnostics, cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility testing services to pharmaceutical, biotechnology, medical device companies, and research institutions. Services are delivered under both GLP-compliant protocols for regulatory submissions (recognized by FDA, EPA, OECD, EEC, JMHW, and JMAFF) and non-GLP study formats for discovery-stage research, with confidentiality and direct technical-staff access positioned as core client-facing principles.

The underlying technology platform is a conventional wet-lab stack spanning PCR (endpoint and TaqMan quantitative real-time), flow cytometry and cell sorting, FISH, G-band karyotyping across multiple mammalian species, STR and SNP genotyping, DNA fingerprinting, Ames and mammalian gene mutation assays, chromosome aberration and micronucleus tests, GLP/GMP-grade plasmid DNA production, and GLP-compliant in vivo animal studies. The wholly-owned RRDA division maintains an AAALAC-, USDA-, and NIH-accredited vivarium that supplies toxicology, PK/ADME, vaccine efficacy, immunogenicity, and medical device testing in rabbits and rodents, plus short- and long-term vivarium leasing.

MDS operates as a project-based, quote-priced CRO with no publicly disclosed fee schedules. Go-to-market is direct enterprise engagement — primarily field sales and relationship-driven — supported by a company website (mds-usa.com), downloadable submission forms, a newsletter channel, and facility audit invitations. Revenue is generated through fee-for-service contracts, with the firm employing between 11 and 50 staff and reporting no parent company, venture capital, or private equity affiliations.

Molecular Diagnostic Services firmographics

Firmographics
Name
Molecular Diagnostic Services
Legal name
Molecular Diagnostic Services, Inc.
Website
https://mds-usa.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
1–10 employees
Short description
Molecular Diagnostic Services is a privately held San Diego-based Contract Research Organization, founded in 1992, providing GLP-compliant molecular diagnostics, toxicology, microbiology, sterility assurance, and biocompatibility testing to pharmaceutical, biotechnology, medical device, and research clients, including in vivo animal studies via its RRDA vivarium division.
Ownership category
akta.pro rank

Molecular Diagnostic Services industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Testing Laboratories and Services (541380), Medical Laboratories (621511)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing

Keywords

  • Contract research services
  • GLP-compliant testing
  • Molecular diagnostics
  • Preclinical toxicology
  • Biocompatibility testing

Where Molecular Diagnostic Services is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Molecular Diagnostic Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: MDS operates as a Contract Research Organization providing comprehensive testing services to pharmaceutical, biotechnology, medical device, and research institutions. Revenue is generated through project-based testing contracts for GLP-compliant and non-GLP studies covering molecular diagnostics, toxicology, microbiology, sterility assurance, and biocompatibility services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Molecular Diagnostic Services product offering

Product offering

Core offering

Molecular Diagnostic Services, Inc. is an independent Contract Research Organization (CRO) operating since 1992, providing comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility testing services to pharmaceutical, biotechnology, medical device, and research institutions. Services are offered both as GLP-compliant studies for regulatory submission (FDA, EPA, OECD, EEC, JMHW, JMAFF) and non-GLP screening for product research and development. The RRDA division adds an AAALAC/USDA/NIH-accredited vivarium for in vivo toxicology, PK/ADME, vaccine efficacy, and surgical procedures.

Product overview

Molecular Diagnostic Services is an independent Contract Research Organization (CRO) operating since 1992, providing comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility services to pharmaceutical, biotechnology, medical device, and research institutions. The company offers a broad portfolio of testing services designed for both GLP-compliant regulatory submission and non-GLP screening for product research and development. Key service areas include Molecular Diagnostics, Clinical Trial Services, Animal Testing Services (through the RRDA division), Antibody Services, Blood Chemistry, Endocrinology, EPA Services, Genotyping, Hematology, Histology, Cell Bank Qualification, In Vivo and In Vitro Toxicity Studies, Immunogenicity, Immunotoxicology, Microbiology, Mutagenesis, Stem Cell Services, Sterility Testing, Vaccine Testing, and Biostatistical Analysis. The company also provides specialized services such as Flow Cytometry, PCR Services (Endpoint, Q-PCR, Species-Specific), DNA Sequencing, FISH Services, Plasmid DNA Production, Custom Cloning, Transgenic Testing, and Expert Witness Services. Services are available for various species including human, murine, bovine, porcine, equine, avian, and others.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Diagnostics Core molecular biology testing services including cellular and molecular biology analysis for pharmaceutical, biotechnology, medical device, and research institutions.
  • Clinical Trial Services Clinical trial support services for regulatory-compliant product testing and evaluation.
  • Rabbit and Rodent Diagnostic Associates (RRDA) Animal Testing Services Animal testing services offering an AAALAC, USDA, and NIH accredited vivarium with GLP or non-GLP toxicology, PK, ADME, drug efficacy, vaccine efficacy, immunogenicity studies, medical device testing, and surgical procedures for laboratory animals. Also offers vivarium space on short or long-term leases.
  • Antibody Services Antibody production and characterization services for research and development applications.
  • Blood Chemistry R&D and CLIA-certified Blood Chemistry Blood chemistry testing services for research and development and CLIA-certified clinical diagnostic applications.
  • Endocrinology Services Endocrine testing and analysis services.
  • EPA Services Environmental Protection Agency-compliant testing services for pesticides and other regulated products.
  • Genotyping Services DNA genotyping services including SNP analysis, STR profiling, DNA fingerprinting, and species identification.
  • Hematology R&D and CLIA-certified Hematology Hematology testing services for research and CLIA-certified clinical diagnostics.
  • Histology R&D and CAP-certified Histology Histological analysis and pathology services including H&E slide preparation and interpretation.
  • Cell Bank Qualification Characterization and qualification of cell banks including Master Cell Banks (MCB) and Working Cell Banks (WCB), covering genetic stability, adventitious agent testing, and cell aging characterization.
  • In Vivo Toxicity Studies GLP-compliant in vivo toxicity testing for pharmaceuticals, biopharmaceuticals, medical devices, and pesticides.
  • In Vitro Toxicity Studies In vitro toxicology testing including genetic toxicity, compound evaluation, and ADME studies.
  • Immunogenicity and Immunotoxicology Services Immunogenicity testing to evaluate immune responses to pharmaceutical and biological products, and immunotoxicity assessment for evaluating adverse immune effects of test articles.
  • Microbiology Services Microbiological testing including bacterial, fungal, mycoplasma detection and identification, microbial identification via 16S rRNA sequencing, environmental monitoring under 21 CFR 58, endotoxin (LAL) testing, and bioburden determination per USP <61>.
  • Mutagenesis Services In vitro and in vivo mutagenesis testing including Ames assay, mammalian gene mutation tests, and chromosomal aberration assays.
  • Stem Cell Services Stem cell culture, characterization, differentiation monitoring, and pluripotency evaluation for therapy development, including pluripotency PCR signature, signaling pathway analysis, and phenotypic characterization.
  • Sterility Testing Biosafety and pharmacopeial sterility testing of biologics and biopharmaceuticals following USP, JP, EP, ICH, 21 CFR, and FDA Points to Consider guidance, including direct inoculation, membrane filtration, preservative efficacy, and bioburden determination.
  • Vaccine Testing Services Characterization and qualification of viral, bacterial, and plasmid DNA vaccines including MCB/WCB characterization, bulk plasmid product release assays, final product release testing, potency, safety, sterility, purity, quantity, identity, endotoxin, DNA sequence analysis, and DNA vaccine modification testing.
  • Biostatistical Analysis Statistical analysis services for research and clinical trial data.
  • Plasmid DNA Production (R&D and GLP/GMP grade) Production of reagent (R&D) grade and GLP/GMP-grade plasmid DNA from microgram to multi-gram amounts, including cell banking, cloning, transfection, and full QC release testing with stringent purity requirements for low endotoxin, host cell chromosomal DNA, and RNA contamination.
  • Expert Witness Services Expert witness testimony services for patent infringement litigation using GLP- and GMP-compliant testing.

Companies that use Molecular Diagnostic Services

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Molecular Diagnostic Services technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Molecular Diagnostic Services partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves2 records

Expansion highlights3 records

Molecular Diagnostic Services competitors and assessment

Company assessment

Direct peers

  • Pharmaron: Integrated CRO with preclinical toxicology, genetic toxicology, molecular biology, and bioanalytical services supporting pharma and biotech drug development. Comparable GLP-compliant service portfolio and similar mid-sized CRO positioning to MDS.
  • Pacific BioLabs: California-based preclinical CRO offering GLP-compliant toxicology, biocompatibility, microbiology, and analytical chemistry testing — a close geographic and capability peer to MDS serving the same San Francisco Bay Area and broader US biotech client base.
  • Inotiv: Preclinical CRO and contract research organization providing toxicology, pathology, and animal model services with GLP compliance. Competes with MDS's RRDA vivarium capabilities and in vivo toxicology services for the same pharma/biotech study budgets.
  • ABC Laboratories: Mid-sized analytical and microbiology testing CRO with GLP-compliant services for pharma, biopharma, and medical device companies. Offers overlapping microbiology, sterility, and analytical testing capabilities that compete with MDS's biosafety service line.
  • BioReliance (Merck/Sigma-Aldrich): Specialized biosafety testing and characterization services for biologics, vaccines, and cell therapy products — including sterility, mycoplasma, adventitious agent testing, and cell line authentication — directly mirroring MDS's biosafety/molecular diagnostic service lines.

Broad incumbents

  • WuXi AppTec: Global CRO/CDMO with preclinical toxicology, molecular biology, and biologics testing capabilities that overlap MDS's service portfolio. Its scale, integrated discovery-to-manufacturing model, and aggressive pricing pressure small specialized CROs like MDS in pharma outsourcing decisions.
  • Charles River Laboratories: Global preclinical CRO offering toxicology, genetic toxicology, molecular biology, and vivarium services that directly overlap MDS's core offerings. A dominant incumbent with vastly greater scale, multi-site capacity, and bundling power that competes for the same pharma/biotech preclinical study budgets.
  • Labcorp Drug Development (formerly Covance): Global clinical and preclinical CRO offering toxicology, genetic toxicology, and molecular biology testing at very large scale. Competes with MDS for both large pharma preclinical packages and provides centralized lab alternatives for biotech sponsors.
  • Eurofins Scientific: International testing services group with significant molecular biology, microbiology, sterility, and GLP-compliant testing operations. Competes with MDS for biotech testing contracts and offers similar genetic toxicology, vaccine testing, and cell bank characterization services at much larger scale.

Regional players

  • NorthEast BioLab: US-based molecular biology and GLP-compliant testing CRO serving pharma and biotech with PCR, sequencing, and cell line characterization services — a regional player offering similar molecular specialty capabilities to MDS but with a different US geography focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Molecular Diagnostic Services social profiles

Digital presence

Molecular Diagnostic Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molecular Diagnostic Services leadership team

Management profile

Number of profiles

Molecular Diagnostic Services subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Molecular Diagnostic Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molecular Diagnostic Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Diagnostic Services

What does Molecular Diagnostic Services do?

Molecular Diagnostic Services, Inc. is an independent Contract Research Organization (CRO) operating since 1992, providing comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility testing services to pharmaceutical, biotechnology, medical device, and research institutions. Services are offered both as GLP-compliant studies for regulatory submission (FDA, EPA, OECD, EEC, JMHW, JMAFF) and non-GLP screening for product research and development. The RRDA division adds an AAALAC/USDA/NIH-accredited vivarium for in vivo toxicology, PK/ADME, vaccine efficacy, and surgical procedures.

Is Molecular Diagnostic Services a public or private company?

Molecular Diagnostic Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Molecular Diagnostic Services founded?

Molecular Diagnostic Services was founded in 1992. It employs 1 to 10 people.

Where is Molecular Diagnostic Services based?

Molecular Diagnostic Services is headquartered in San Diego, United States, in the North America region.

How does Molecular Diagnostic Services make money?

One revenue line is on record: contract Research Services.

Who are Molecular Diagnostic Services's main competitors?

Direct peers on record are Pharmaron, Pacific BioLabs, Inotiv, ABC Laboratories and BioReliance (Merck/Sigma-Aldrich). Broad incumbents are WuXi AppTec, Charles River Laboratories, Labcorp Drug Development (formerly Covance) and Eurofins Scientific. NorthEast BioLab is listed as a regional player.

Does Molecular Diagnostic Services have an API?

No public API is recorded for Molecular Diagnostic Services.

What industry is Molecular Diagnostic Services in?

Molecular Diagnostic Services's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales